Improving DxMultiomics, Powered by Your Choices

We're building DxMultiomics to be The Central Nexus of Biotech Intelligence. To ensure a seamless experience and continuous improvement, we utilize website analytics. These tools help us monitor site performance, understand how users navigate the platform, and identify opportunities to make your research journey more efficient. We handle this data with the utmost respect for your privacy, and you can choose what works best for you.

Polaris Quantum Biotech (PolarisQB), a leader in Quantum Computing for drug discovery, created the first drug discovery platform built on a Quantum Computer, Quantum-Aided Drug Design (QuADD). Founded in 2020 in Durham, North Carolina, PolarisQB utilizes the latest advancements in quantum and cloud computing, artificial intelligence, and machine learning to identify drug lead molecules from a chemical space comprising 10^30 molecular options. The QuADD platform can search a massive chemical space and deliver molecules specific to on-demand libraries, as well as de novo space. Final candidates, identified in minutes, possess custom drug-like characteristics for the discovery project and are represented in 3D conformations within the target protein pocket.